| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.093 | 0.07 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.07 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.31 | 0.07 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.092 | 0.08 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |